It would seem that there is much success with Zenith going forward.

With regards to funding BOM2 with Zenith's royalties, that is a long road especially when Zenith's cancer pipeline needs to get through Phase 3 which has not begun and needs to be successful. How will Resverlogix be funded in the meantime?

If it's decided that Zenith will be supporting Resverlogix financially for BOM2, IMO, an IPO on Nasdaq with a strong investment bank would be the quickest way to get the necessary funding. I believe Zenith has the necessary pipelines as things stand and is ready for it. And will give shareholders stock liquidity.

Koo